// App-Quantinova.ai

: A Validation, with New Clinical Applicability, of a Clinical‐genetic Risk Model that Predicts Thrombosis with High Sensitivity in Patients with Lymphoma

Researchers

Presenter

  • M. Bastos

Principal Investigators

  • J. Ortiz

  • V. Pradillo

  • C. Martinez-Laperche

  • E. Salas

  • I. Buno

  • J.L. Diez-Martin

  • J.M. Soria

  • C. Pascual

Medical Centers

  • Hospital Universitario Gregorio Marañon, Hematología y Hemoterapia, Madrid, Spain

  • Instituto de investigacion sanitaria gregorio maranon, Madrid, Spain

  • Institut d'Investigació Sant Pau, Genomic of Complex Diseases, Barcelona, Spain

  • Universidad Complutense de Madrid, Madrid, Spain

Locations

  • Spain

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Pulmonary/Respiratory Diseases

  • Blood/haematological Diseases

  • Cardiovascular (CVS)

Disease

  • Venous thrombosis

  • Lymphomas

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A